NL8105749A - Xanthinederivaten, werkwijzen ter bereiding ervan alsmede farmaceutische preparaten, die deze derivaten bevatten. - Google Patents

Xanthinederivaten, werkwijzen ter bereiding ervan alsmede farmaceutische preparaten, die deze derivaten bevatten. Download PDF

Info

Publication number
NL8105749A
NL8105749A NL8105749A NL8105749A NL8105749A NL 8105749 A NL8105749 A NL 8105749A NL 8105749 A NL8105749 A NL 8105749A NL 8105749 A NL8105749 A NL 8105749A NL 8105749 A NL8105749 A NL 8105749A
Authority
NL
Netherlands
Prior art keywords
methyl
xanthine
pharmacologically acceptable
general formula
nitrogen
Prior art date
Application number
NL8105749A
Other languages
English (en)
Dutch (nl)
Original Assignee
Fordonal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordonal Sa filed Critical Fordonal Sa
Publication of NL8105749A publication Critical patent/NL8105749A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8105749A 1980-12-23 1981-12-21 Xanthinederivaten, werkwijzen ter bereiding ervan alsmede farmaceutische preparaten, die deze derivaten bevatten. NL8105749A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8041247 1980-12-23
GB8041247 1980-12-23
GB8121332 1981-07-10
GB8121332 1981-07-10

Publications (1)

Publication Number Publication Date
NL8105749A true NL8105749A (nl) 1982-07-16

Family

ID=26277965

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8105749A NL8105749A (nl) 1980-12-23 1981-12-21 Xanthinederivaten, werkwijzen ter bereiding ervan alsmede farmaceutische preparaten, die deze derivaten bevatten.

Country Status (16)

Country Link
AR (1) AR229037A1 (el)
AU (1) AU7868481A (el)
DE (1) DE3150550A1 (el)
DK (1) DK571581A (el)
ES (1) ES508103A0 (el)
FI (1) FI814105L (el)
FR (1) FR2498602A1 (el)
GR (1) GR76972B (el)
IT (1) IT1195301B (el)
LU (1) LU83849A1 (el)
MA (1) MA19357A1 (el)
NL (1) NL8105749A (el)
NO (1) NO814373L (el)
NZ (1) NZ199340A (el)
PT (1) PT74190B (el)
SE (1) SE8107683L (el)

Also Published As

Publication number Publication date
DK571581A (da) 1982-06-24
DE3150550A1 (de) 1982-08-12
ES8304980A1 (es) 1983-04-01
AU7868481A (en) 1982-07-01
PT74190A (en) 1982-01-01
NO814373L (no) 1982-06-24
PT74190B (en) 1983-05-20
ES508103A0 (es) 1983-04-01
IT1195301B (it) 1988-10-12
MA19357A1 (fr) 1982-07-01
NZ199340A (en) 1984-07-06
FR2498602A1 (fr) 1982-07-30
GR76972B (el) 1984-09-04
SE8107683L (sv) 1982-06-24
AR229037A1 (es) 1983-05-31
IT8125728A0 (it) 1981-12-21
FI814105L (fi) 1982-06-24
LU83849A1 (en) 1982-05-07

Similar Documents

Publication Publication Date Title
CA2350538C (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
JP2896532B2 (ja) 新規なピリミジン誘導体およびその製造方法
DE60101158T2 (de) 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren
JP2928386B2 (ja) うつ病治療剤
JP2000072773A (ja) プリン誘導体
NO884835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-furo-og-tieno (2,3.-c)pyridiner.
PL101141B1 (pl) Sposob wytwarzania nowych pochodnych chinazolonu
US20080255110A1 (en) Imidazoquinoline derivatives as adenosine a3 receptor ligands
JPH08269059A (ja) 新規のピリド[3,2−e]ピラジノン及びその製法、これを含有する抗喘息及び抗アレルギー作用を有する薬剤及びこの薬剤の製法
US3993656A (en) 1,8-Naphthyridine compounds
WO2021022788A1 (zh) 一种5-氟尿嘧啶的组合物及其精制方法
KR102254660B1 (ko) A2a수용체 억제제로서의 축합 고리 유도체
CN102015711A (zh) 用于治疗寄生虫病的螺-吲哚衍生物
NO175978B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
CN109134463B (zh) β-咔啉类5型磷酸二酯酶抑制剂及其制备方法和用途
IE901055L (en) Diazepine antiallergy agents
FR2523582A1 (fr) Nouvelles 1h-pyrazolo(1,5-a)pyrimidines substituees, utiles notamment comme medicaments anti-inflammatoires et analgesiques, et procede pour leur preparation
JPS623153B2 (el)
JP5366211B2 (ja) アルドース還元酵素阻害活性を有する縮合三環化合物
EP0383465A2 (en) Tricyclic fused pyrimidine derivatives, their production and use
US20210032239A1 (en) Compounds and pharmaceutical compositions for modulating sgk activity, and methods thereof
GB2091249A (en) Xanthine derivatives
CA1287631C (en) 5-substituted-6-aminopyrimidine derivatives, composition and uses
JP2000501420A (ja) 新規なトリアゾロプリン類、その調製方法及び医薬組成物としての使用
JPS61145183A (ja) 新規イミダゾ誘導体

Legal Events

Date Code Title Description
BV The patent application has lapsed